Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00318)
| DIG Name |
Cysteine hydrochloride
|
||||
|---|---|---|---|---|---|
| Synonyms |
DL-Cysteine hydrochloride; 10318-18-0; 2-amino-3-mercaptopropanoic acid hydrochloride; CYSTEINE HYDROCHLORIDE; DL-CYSTEINE HCL; H-DL-Cys-OH.HCl; H-D-Cys-OH HCl HO; MFCD00064552; Cystein chloride; NSC8746; DL-2-Amino-3-mercaptopropionic acid hydrochloride; H-D-Cys-OH.HCl.H2O; Cysteine chlorhydrate; (+-)-Cysteine hydrochloride; DL-Cysteine hydrochloride anhydrous; DL-Cysteine hydrochloride, 95%, anhydrous; CYSTEINE, HYDROCHLORIDE, DL-; EINECS 233-698-2; 3-Mercaptoalanine hydrochloride; L-Cysteine, hydrochloride (1:1); MFCD00012632; EK 2367; Cysteine chlorohydrate; H-DL-Cys-OH?Cl; L-Cystein-hydrochloride; ACMC-20al3w; DL-CysteineHydrochloride; H-DL-Cys.HCl.H2O; CYSTEINE, (L); 2-amino-3-sulfanylpropanoic acid hydrochloride; ACMC-20a6d7; (R)-Cysteine-hydrochloride; (RS)-cysteine hydrochloride; SCHEMBL18160; (2S)-2-amino-3-sulfanylpropanoic acid;hydrochloride; ARONIS005073; WLN: SH1YZVQ &GH -L; DTXSID00920537; Pharmakon1600-01300014; Cysteine--hydrogen chloride (1/1); NSC755898; AKOS003726073; MCULE-7790846545; NSC-755898; AK-49861; DS-15293; SY033289; AB0068970; DB-007444; DB-048214; DB-052197; AM20070682; FT-0624466; FT-0627749; FT-0639023; FT-0650774; C-9675; M-5521; 2-azanyl-3-sulfanyl-propanoic acid hydrochloride; 318C180; A814830; DL-Cysteine hydrochloride, >=95% (TLC), anhydrous
|
||||
| DIG Function |
Antioxidant
|
||||
| Formula |
C3H8ClNO2S
|
||||
| Canonical SMILES |
C(C(C(=O)O)N)S.Cl
|
||||
| InChI |
1S/C3H7NO2S.ClH/c4-2(1-7)3(5)6;/h2,7H,1,4H2,(H,5,6);1H
|
||||
| InChIKey |
IFQSXNOEEPCSLW-UHFFFAOYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 157.62 | Topological Polar Surface Area | 64.3 | |
| XlogP | N.A. | Complexity | 75.3 | ||
| Heavy Atom Count | 8 | Rotatable Bond Count | 2 | ||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | ||
Full List of Drug(s) Co-administrated with This DIG